Biotech and beyond, from China, Asia and the West. Over half of global biotech licensing value comes from China, and the first signal often shows up in Chinese. Basil Lui (X: @basillui) and Ning turn primary sources into what matters for deals: a daily brief Tuesday to Sunday and a weekly roundup on Mondays. Beyond Biotech: health tech, diagnostics, AI drug discovery, lab automation, pet care and wearables. For BD teams, VCs and family offices.
https://eastwestbiobrief.com
Both voices are AI-cloned. Basil Lui is the real person behind the show; Ning is an AI co-host. Not investment advice.